New hope for treating heart failureMarch 07, 2017
(Edmonton) Heart failure patients who are getting by on existing drug therapies can look forward to a far more effective medicine in the next five years or so, thanks to University of Alberta researchers.
Heart specialist Gavin Oudit and his research team discovered a molecule--angiotensin converting enzyme 2 (ACE2)--that works to restore balance to the pathways responsible for chronic and acute heart failure, including in patients with advanced heart failure who underwent heart transplants.
In conducting their research, Oudit and his team used genetic mapping technology to discover to an extent not seen before how the renin-angiotensin system (RAS)--which regulates the body's sodium balance, fluid volume and blood pressure--is at play in both acute and chronic heart failure.
It led to the creation of recombinant human ACE2, a new drug that was manufactured by Apeiron Biologics in collaboration with Oudit. It was bought by GlaxoSmithKline, which recently successfully completed phase II clinical trials that tested for the safety and efficacy of the drug on hundreds of patients. The new drug is expected to be on the market in the next three to five years.
Oudit added that using mapping technology has also made it possible to individualize the dose a patient needs, allowing for a truly personalized treatment plan for heart failure patients in the future. The study also broke ground by showing how ACE2 can be used in heart transplant patients with heart failure.
About six million Canadians will develop heart failure, a common condition that most often happens after the heart has been damaged or weakened by heart attack or stroke. According to the Canadian Heart and Stroke Foundation, the two most common causes of heart failure are heart attacks and high blood pressure. When someone has heart failure, the heart either can't accept the inflow of blood or pump it out, or both.
"This research is a terrific example of how the university works together synergistically to develop world-class research and translate that into medicines that impact patient outcomes," added Oudit.
The research was funded by Alberta Innovates, the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada.
University of Alberta Faculty of Medicine & Dentistry
Related Heart Failure Articles:
Heart failure patients who are getting by on existing drug therapies can look forward to a far more effective medicine in the next five years or so, thanks to University of Alberta researchers.
Chronic inflammation after a heart attack can promote heart failure and death.
Does a stay in the intensive care unit give patients a better chance of surviving a chronic obstructive pulmonary disease (COPD) or heart failure flare-up or even a heart attack, compared with care in another type of hospital unit?
Researchers have grown heart tissue by seeding a mix of human cells onto a 1-micron-resolution scaffold made with a 3-D printer.
Smokers without obvious signs of heart disease were more likely than nonsmokers and former smokers to have thickened heart walls and reduced heart pumping ability.
During a heart attack, clots or narrowed arteries block blood flow, harming or killing cells in the heart.
People who develop heart failure after their first heart attack have a greater risk of developing cancer when compared to first-time heart attack survivors without heart failure, according to a study today in the Journal of the American College of Cardiology.
A team of researchers have created a detailed computational model of the electrophysiology of congestive heart failure, a leading cause of death.
In a study published online by JAMA Cardiology, Elizabeth Selvin, Ph.D., M.P.H., of the Johns Hopkins Bloomberg School of Public Health, Baltimore, and colleagues examined the association of six-year change in high-sensitivity cardiac troponin T with incident coronary heart disease, heart failure and all-cause mortality.
One in four patients develop heart failure within four years of a first heart attack, according to a study in nearly 25,000 patients presented today at Heart Failure 2016 and the 3rd World Congress on Acute Heart Failure by Dr.
Related Heart Failure Reading:
Heart Failure: A Companion to Braunwald's Heart Disease, 3e
by Douglas L. Mann MD (Author), G. Michael Felker MD MHS FACC FAHA (Author)
Lead editor of Braunwald’s Heart Disease, Dr. Douglas L. Mann, and nationally and internationally recognized heart failure expert Dr. G. Michael Felker, bring you the latest, definitive state-of-the art information on heart failure in this outstanding Braunwald’s companion volume. Heart Failure, 3rd Edition, keeps you current with recent developments in the field, improved patient management strategies, and new drug therapies and implantable devices that will make a difference in your patients’ lives and in your practice. Braunwald’s Heart Failure... View Details
by Richard Mabry (Author)
When her fiancé’s dangerous secrets turn her work upside down, a beautiful doctor must choose between her own safety and the man she loves—and thought she knew.
Dr. Carrie Markham’s heart was broken by the death of her husband two years ago. Now, just as her medical practice is taking off, her fresh engagement to paralegal Adam Davidson seems almost too good to be true . . . until a drive-by shooting leaves Carrie on the floor of his car with glass falling around her.
When he confesses that Adam isn’t his real name and that he fled the witness protection program,... View Details
Oxford Textbook of Advanced Heart Failure and Cardiac Transplantation
by Michael Domanski (Editor), Mandeep R. Mehra (Editor), Marc Pfeffer (Editor)
Heart failure is epidemic throughout the world. A growing incidence and prevalence has resulted in a large population of individuals transitioning to advanced stages of the syndrome and requiring uniquely specialised therapies and cardiac transplantation.
Oxford Textbook of Advanced Heart Failure and Cardiac Transplantation is a focused and comprehensive work covering this new and rapidly growing cardiovascular subspecialty. Authored by eminent international experts, it is the authoritative text on advanced heart failure and a central resource for clinicians caring for patients with... View Details
Heart Failure Pocketcard Set
by M.D. Szady (Author), M.D. Bavry (Author)
Heart Failure: A Practical Guide for Diagnosis and Management (Oxford American Cardiology Library)
by Stuart Katz (Author), Ragavendra Baliga (Series Editor)
Clinical practice consensus guidelines for management of heart failure are available from the American Heart Association/American College of Cardiology, Heart Failure Society of America, Canadian Cardiovascular Society, and European Society of Cardiology. The guidelines from these organizations, based on evidence from clinical trials and expert agreement, are largely concordant and provide useful information for practitioners. Yet, the organization of the guidelines may confound efforts by a practitioner to determine which specific intervention, or combination of interventions, are most... View Details
Heart Failure Recovery: Complete Failure to Complete Recovery
by Ray Reynolds (Author)
”Our knowledge of human biology doubles every four years.” This makes it nearly impossible for physicians to stay current on the latest research in their own fields let alone in all of the others that directly effect their ability to properly treat their patients. In this new book by Bio Researcher Ray Reynolds you will learn... How heart muscle cells have the ability to stay alive by hibernating when deprived of oxygen. The four nutriants needed to revive them after the coranary artery blockage has been removed. How to utilize minimum effective doses of heart medications to regulate... View Details
Heart Failure: A Comprehensive Guide to Pathophysiology and Clinical Care
by Howard Eisen (Editor)
This comprehensively covers everything from pathophysiology to the evaluation of patients presenting with heart failure to medical management, device therapy, heart transplantation and mechanical circulatory support, and include relevant cardiac imaging studies such as echocardiograms and magnetic resonance imaging studies which could be seen in their entirety as well as pathology slides, hemodynamic tracings and videos of cardiac surgery such as heart transplants and ventricular assist device implantation. Finally, the book would have videos of patients with heart failure, heart transplants... View Details
Living Well with Heart Failure, the Misnamed, Misunderstood Condition
by Edward K. Kasper (Author), Mary Knudson (Author)
Heart failure―the expression alone is scary. The idea that the blood-pumping organ in our chest can struggle, stutter, or suddenly stop is deeply disconcerting. But for those who get the diagnosis, the future is not necessarily bleak. With the right treatments and a healthy lifestyle that includes exercise and good nutrition, many people with heart failure can improve their condition and live well.
Heart failure expert Edward K. Kasper, M.D., teams with journalist―and survivor―Mary Knudson to give readers an honest account of this misunderstood condition. The authors... View Details
The 4 Stages of Heart Failure
by Brian Jaski (Author)
If you understand heart failure, you understand cardiology This book applies practical clinical concepts to the latest four-stage model of heart failure from preclinical risk and early asymptomatic disease to classic symptomatic heart failure and finally advanced heart failure. This framework emphasizes a tailored approach to ongoing heart failure assessment to guide therapy and improve outcomes. View Details
MemoCharts Pharmacology: Drug Therapy for Congestive Heart Failure (Review chart)
by Howard Shen (Author)
An integrated minireview of drug therapy used for congestive heart failure (CHF), illustrated with visually appealing tables and diagrams. Updated with the latest heart failure management guidelines and new drugs like If inhibitor Ivabradine. A quick visual aid for the course study and board review View Details